On a journey to feel a little better. Or BEDDA.
Not Applicable
- Conditions
- Prevention of depressionMental and Behavioural Disorders
- Registration Number
- ISRCTN38841716
- Lead Sponsor
- ETH Zurich
- Brief Summary
2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37349832/ (added 23/06/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1. Aged 18 years old and over
2. Residency in Switzerland
3. Understand of mid-level English or German (B1-B2)
Exclusion Criteria
1. Current diagnosis with or in treatment for a mental health disease
2. Asthma, COPD, or any other lung or respiratory tract disease
3. Pregnancy
4. Scoring greater than 15 for symptom severity of depression and anxiety in the PHQ-9 and GAD-7 instruments, respectively
5. Positive response to the last question of the PHQ-9, accessing suicide ideation or self-harm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Depression severity measured using the nine-question version of the Patient Health Questionnaire (PHQ-9) at baseline, after 14 interactions, and at the end of the intervention (after 30 interactions). <br>2. One of three randomly selected symptoms of depression (mood, agitation, anhedonia) measured using the Multidimensional Mood State Questionnaire (MDMQ) on a daily basis<br> 3. Physiological (such as heart-rate-variability) and behavioral (such as physical activity) outcomes measured using a Garmin Smartwatch Fitness Tracker in a sub sample of 25% of the participants
- Secondary Outcome Measures
Name Time Method Anxiety severity measured using the seven-question version of the General Anxiety Disorder questionnaire (GAD-7) and stress using the short version of the Trier Inventory for Chronic Stress at baseline, after 14 interactions, and at the end of the intervention (after 30 interactions)